Industry News
Synarc Expands Global Imaging Services for Cardiology and Neurovascular Trials
Dionex Corporation and EMD Millipore Announce Distribution Agreement for Ion Chromatography Water Purification System
Gilead Provides Update on $5 Billion Stock Repurchase Program
Cellerant Therapeutics Awarded $153 Million Contract By Biomedical Advanced Research And Development Authority (BARDA) To Develop Treatment For Acute Radiation Syndrome (ARS)
Varian Medical Systems Establishes Radiotherapy Training Center in Mumbai, India
OptiMedica's Laser Cataract Surgery System to be Featured in Three Clinical Presentations at ESCRS
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
Maquet SA Adopts Agilent Electronic Lab Notebook Paired with Surety Intellectual Property Integrity Protection
Agilent Technologies Introduces Sample Prep Workbench
StemCells, Inc's Technology Used to Create First Genetically Engineered Rat Derived from Rat Embryonic Stem Cells
Swiss Breast Cancer Patient Becomes First in World to Receive Treatment Using Gated RapidArc from Varian Medical Systems
NIAID Grant to Fund Dynavax Research on Hepatitis B Vaccination and Individual Variations in Human Responsiveness
American Shared Hospital Services Announces Contract to Supply Radiation Therapy Services in Sao Paulo, Brazil
McKesson Releases New Reporting Solution for EnterpriseRx
Portola Pharmaceuticals Announces that Phase II INNOVATE-PCI Trial with Elinogrel Achieved Objectives
Thermogenesis Announces Sale Of Bioarchive Systems In Asia As Company Increases Presence In Key Market
BioMarin Receives Orphan Drug Designation from the FDA for BMN-701 for the Treatment of Pompe Disease
Advanced Cell Technology's Robust Cell Reprogramming/Transdifferentiation Platform Well Positioned To Capitalize on Emerging Trends in Regenerative Medicine
Bionovo Announces Reverse Stock Split
Bionovo Receives Positive Guidance from FDA on Menerba
Portola Pharmaceuticals Announces Presentation of New Pharmacodynamic Data from Phase II Trial of Investigational Factor Xa Inhibitor, Betrixaban
First Isolation of Full-Length BRCA2 Protein Enabled by Bio-Rad Mini-PROTEAN TGX Precast Gels
New Distributor - Interprise Brasil
McKesson and HFMA Join Forces to Offer Health Reform Webinar Series
Thermogenesis Announces Reverse Stock Split Effective On NASDAQ Capital Market August 27, 2010
XOMA Appoints Jack L. Wyszomierski to Its Board of Directors
Solazyme adds Bunge as Strategic Investor in Series D
XenoPort Announces Changes to Executive Team
Alexza's Staccato Nicotine Licensed to Cypress Bioscience
Plexxikon Publishes PLX4032 Phase I Data Demonstrating 81 Percent Response Rate in Metastatic Melanoma Patients in the New England Journal of Medicine
FibroGen Announces Results of 2-Year Study Demonstrating that Biosynthetic Corneas Formulated with Recombinant Human Type III Collagen Restore Vision and Promote Nerve Regeneration
New T.Ox IO Sensor
Data on Vivus'Qnexa to Be Presented at the European Society of Cardiology Congress
Impax Pharmaceuticals Completes Enrollment in ADVANCE-PD Phase III Trial of IPX066 in Parkinson's Disease
